Sara C. Granja

Porto, 4200072, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer.

Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer.

Journal: Cell biology and toxicology

Published: June 20, 2025

Metabolism-targeted therapy in NSCLC - A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24).

Metabolism-targeted therapy in NSCLC - A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24).

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 29, 2025

3-Bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by a pro-oxidant mechanism.

3-Bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by a pro-oxidant mechanism.

Journal: Free radical biology & medicine

Published: February 10, 2025

Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.

Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.

Journal: Pharmaceutics

Published: March 05, 2024

In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer.

In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer.

Journal: RSC medicinal chemistry

Published: December 04, 2023

Combination Therapy With CD147-Targeted Nanoparticles Carrying Phenformin Decreases Lung Cancer Growth.

Combination Therapy With CD147-Targeted Nanoparticles Carrying Phenformin Decreases Lung Cancer Growth.

Journal: Advanced biology

Published: February 16, 2023

Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative.

Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative.

Journal: International journal of molecular sciences

Published: November 28, 2022

MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma.

MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma.

Journal: Cancers

Published: May 18, 2021

Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186.

Cancer Cells' Metabolism Dynamics in Renal Cell Carcinoma Patients' Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186.

Journal: Cancers

Published: March 23, 2021

Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.

Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.

Journal: International journal of pharmaceutics

Published: February 18, 2021

Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism.

Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Immunohistochemical Assessment of Markers of Cancer Cell Metabolism.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: February 05, 2021

Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.

Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.

Journal: Drug delivery and translational research

Published: July 20, 2020

Showing 1-12 of 39

Last Updated: 09/26/2026